Safety
-
Eligard (leuprolide acetate) injection
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – February 2013
ADVERSE REACTIONS
Post-Marketing
- convulsions
-
-







